Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 12,017

Document Document Title
WO/2018/008737A1
The present invention addresses the problem of providing a compound which exerts its effect on the onset mechanism of Parkinson's disease by inhibiting the degeneration and cell death of dopamine-secreting cells, and a therapeutic or pro...  
WO/2018/004606A1
Complexation of metal ions using chelating agents within a subterranean formation can often be desirable, such as to temper the formation of metal-containing precipitates. However, many chelating agents are produced commercially in an al...  
WO/2018/003980A1
The present invention addresses the problem of providing a crystal of a pharmacologically acceptable salt of a bicyclic aminocarboxylic acid derivative. The solution is a crystal of [(1R,5S,6S)-6-(aminomethyl)-3-ethylbicyclo[3.2.0]hept-3...  
WO/2018/000404A1
Provided in the present application is a method for preparing taurine, characterized in comprising the following steps: (a) mixing isethionate with a taurine salt solution so that the system pH reaches a certain value between 5.0 and 9.5...  
WO/2017/220512A1
The present invention relates to a compound according to Formula (3), wherein the compound comprises from 28 wt.% to 100 wt.% bio-based carbon content, relative to the total mass of carbon in the compound, measured according to standard ...  
WO/2017/217757A1
The present invention relates to modified taurine and a method for preparing the same and, more particularly, to modified taurine different from conventional taurine in a distance between an intramolecular carbon (C) atom and a sulfur (S...  
WO/2017/217553A1
[Problem] To provide a novel agricultural chemical, and particularly an herbicide. [Solution] An oxime compound represented by formula (1) and an herbicide containing the same. (In formula (1): B represents B-1 or the like; Q represents ...  
WO/2017/218764A1
Provided is a method of preparing isosulfan blue.  
WO/2017/217455A1
Provided is an electron-accepting substance precursor comprising a sulfonic acid ester compound represented by formula (1). (In the formula, R1-R4 each independently represent a hydrogen atom, or a straight-chain or branched C1-6 alkyl g...  
WO/2017/217457A1
Provided is a sulfonic acid ester compound represented by formula (1). (In the formula, R1 and R2 each independently represent a hydrogen atom, or a straight-chain or branched monovalent aliphatic hydrocarbon group. R3 represents a strai...  
WO/2017/209120A1
The present invention relates to a liquid detergent composition for textile products which includes: at least 10 mass% but not more than 60 mass% of component (A), namely C17-24 internal olefin sulfonates wherein the mass ratio (IO-1S)/(...  
WO/2017/209117A1
The present invention relates to a detergent composition for fibres which includes: component (A), namely C17-24 internal olefin sulfonates; component (B), namely a nonionic surfactant; and component (C), namely a metal ion chelating age...  
WO/2017/204149A1
The purpose of the present invention is to provide: a detergent composition which exhibits excellent detergency against solid fat-containing oil stains attached to hard surfaces of hard articles such as plastics; and a detergent-use surf...  
WO/2017/201076A1
The present disclosure provides one or more amino lipids such as an amino lipids containing a sulfonic acid or sulfonic acid derivative of the formulas: Formula (I) or (IV) wherein the variables are as defined herein. These amino lipids ...  
WO/2017/196859A1
The present invention provides a new crystalline form of itraconazole as well as the method of making same.  
WO/2017/188297A1
Provided is a resist composition that improves acid generation efficiency and is used to produce a photoresist having high sensitivity, high resolution, and high LWR properties. The present invention relates to a compound represented by ...  
WO/2017/179727A1
The present invention is a radiation sensitive resin composition which contains a polymer having a first structural unit that contains an acid-cleavable group, a first radiation sensitive acid generator and a solvent, and wherein the fir...  
WO/2017/162545A1
The invention relates to a method for producing acrylamido tertiary-butyl sulfonic acid by determining the water content of a water-containing acrylonitrile and mixing the water-containing acrylonitrile with oleum, the dissolved sulfur t...  
WO/2017/154345A1
The present invention provides: an active light sensitive or radiation sensitive resin composition which is capable of forming a pattern that has low LWR and is suppressed in collapsing; a resist film; a pattern forming method; and a met...  
WO/2017/155217A1
Provided is a method for acidifying a terephthalylidene dicamphor sulfonic acid salt to convert the terephthalylidene dicamphor sulfonic acid salt to a terephthalylidene dicamphor sulfonic acid, and specifically, a method for converting ...  
WO/2017/149331A1
A method of producing aqueous solutions of N-bromotaurine (Taurine Bromanine, NBrT) with excess taurine (in a ratio 1:5) with later addition of NaOBr. Emulsions of these solutions with Stable Produced Olive Oil (S.P.O.O.) for use against...  
WO/2017/145716A1
In this production method according to the present disclosure, a 1,1'-binaphthyl derivative precursor having, at each of the 2-position and 2'-position of a 1,1'-binaphthyl skeleton, an electron-donating group including an oxygen atom di...  
WO/2017/142740A1
Described herein are improved processes for the preparation of the 7H-pyrrolo[2,3-d]pyrimidine compound, N-methyl-1-{trans-4-[methyl(7H-pyrrolo[2, 3-d]pyrimidin-4-yl)amino]cyclohexyl}-methanesulfonamide, intermediates thereof, and veteri...  
WO/2017/132755A1
The present disclosure provides: floridoside or isethionic acid for use as an antibiotic potentiator; floridoside or isethionic acid in a combination therapy with an antibiotic compound; as well as methods of potentiating the antibiotic ...  
WO/2017/128201A1
The present invention relates to a fluorescent whitening agent composition. The fluorescent whitening agent composition consists of water, a stilbene-triazine compound as shown by formula (I) and a sodium methylenebisnaphthalenesulphonat...  
WO/2017/122697A1
The present invention provides a radiation-sensitive resin composition that contains: a first polymer having a first structural unit that contains a first acid-dissociable group; a radiation-sensitive acid generator; and a compound repre...  
WO/2017/114456A1
The present invention provides a novel, pharmaceutically acceptable salt of a morpholine derivative, including malate salt, tartrate salt, hydrochloride salt, acetate salt and naphthalene diphosphate salt. The tartrate salt has three cry...  
WO/2017/111032A1
To provide a heat-sensitive recording material which has excellent water resistance in a print part, while having excellent heat resistance in a background part. A heat-sensitive recording material which is characterized by containing at...  
WO/2017/111598A1
The invention relates to a method for preparing a compound comprising two phenyl groups by reacting a bisfuranic compound with a dienophile; and to such compounds.  
WO/2017/099662A1
A method for producing derivatives of N-retinoylaminoalkane sulfonic acid, the method comprising providing retinoic acid, chloroformate, aminoalkanesulfonic acid selected from the group consisting of cysteic acidand alkyl ester thereof, ...  
WO/2017/100213A1
The present invention relates to stabilization of one or more component of a PCR or RT-PCR reaction mixture at ambient temperatures. In particular, formulations, compositions, articles of manufacture, kits and methods for substantially s...  
WO/2017/094458A1
An electrochemical light emitting cell (10) includes a light emitting layer (12) and electrodes (13), (14) disposed on surfaces of the light emitting layer (12). The light emitting layer (12) contains an organic polymer light emitting ma...  
WO/2017/093209A1
The present invention relates to a process for preparing 3-amino tetrahydropyrans and, more particularly, to an improved method for synthesizing a 2,3,5-substituted tetrahydropyran derivative, intermediate being used in the preparation o...  
WO/2017/091453A1
Disclosed herein is a novel process for preparing substituted quinazoline compounds of formula (I) using a hydrogen bonding catalyst.  
WO/2017/083983A1
The present disclosure generally relates to compounds comprising homotaurine that may be used in improving the general mental condition and/or general brain function of a non- human animal, and for the prophylaxis of chronic, aging-relat...  
WO/2017/080991A1
The invention relates to a method for purifying alkanesulfonic acids, having the following steps: (a) distilling a melt which contains raw alkanesulfonic acid (1) in order to completely or partly separate low-boiling constituents, wherei...  
WO/2017/080994A1
The invention relates to a process for reprocessing alkane sulfonic acid, which is used in a chemical process as an agent, catalyst, or solvent, which comprises the following steps: (a) separating a stream containing alkane sulfonic acid...  
WO/2017/079538A1
The present invention concerns compounds useful as probes for detecting modified amino acids in peptides or proteins.  
WO/2017/069192A1
The present invention addresses the problem of providing a stabilizer of 8-amino-5-chloro-7-phenylpyrido[3,4-d]pyridazine-1,4(2H,3H)- dione (L-012) or a salt thereof with which it is possible to suppress a decline in measurement sensitiv...  
WO/2017/063155A1
The present invention provides compounds of formula I. The present invention also provides a preparation method for the compounds and a medicine composition comprising the compounds. The medicine composition can be used for treating a bo...  
WO/2017/050769A1
The present invention concerns thermotropic ionic liquid crystal molecules, comprising a so-called rigid part, a so-called flexible part bonded covalently, directly or via a spacer, to said rigid part, and one or more ionic groups bonded...  
WO/2017/049343A1
The present invention relates novel methods of synthesizing terphenyl compounds and in particular to novel methods for the synthesis of a compound of Formula I or intermediates thereof.  
WO/2017/050092A1
Provided is a method for preparing an intermediate of formula II for odanacatib, comprising a step of reducing the compound of formula II to a compound of formula IA, wherein the reduction is performed by adding a metal chloride and a me...  
WO/2017/046546A1
The invention relates to a method for producing 2-acrylamido-2-methylpropane sulfonic acid. Said method consists in reacting together acrylonitrile, fuming sulphuric acid and isobutylene. It is characterised in that the isobutylene conta...  
WO/2017/048528A1
Disclosed are a variety of amphoteric compounds containing a quaternary nitrogen group, a covalently bound counterion, and an ester or amide group. These amphoteric compounds can be advantageously prepared via a chemoenzymatic green proc...  
WO/2017/044840A1
Disclosed herein are methods for treating, ameliorating, and/or preventing Alzheimers Disease in a specific patient population using tramiprosate, valyl-3-amino-1-propanesulfonic acid, or a pharmaceutically acceptable salt thereof based ...  
WO/2017/022629A1
This liquid detergent includes: component (a), namely an α-sulfo-fatty acid alkyl ester salt represented by the formula {R3CH(SO3M)COOR4} (R3 is a C10-16 hydrocarbon group, R4 is a C1-6 hydrocarbon group, and M is a counter ion); and co...  
WO/2017/021112A1
The invention relates to surfactants of the general formula (I), in which R1 stands for a linear or branched alkyl radical having 6 to 20, in particular 8 to 14 C-atoms, R2 stands for H or CH3, and M stands for hydrogen, an alkali metal ...  
WO/2017/022788A1
This lubricant comprises an ionic liquid that includes a conjugate acid and a conjugate base having at least two anions in a molecule, the conjugate acid having a group that includes a linear hydrocarbon group with at least six carbon at...  
WO/2017/024009A1
β-Substituted β-amino acids, β-substituted β-amino acid derivatives, and β-substituted β-amino acid analogs and (bio)isosteres and their use as chemotherapeutic agents are disclosed. The β-substituted β-amino acid derivatives and...  

Matches 1 - 50 out of 12,017